Newborn screening for Pompe disease in Italy: Long-term results and future challenges

Pompe disease (PD) is a progressive neuromuscular disorder caused by a lysosomal acid α-glucosidase (GAA) deficiency. Enzymatic replacement therapy is available, but early diagnosis by newborn screening (NBS) is essential for early treatment and better outcomes, especially with more severe forms. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Gragnaniello, Vincenza, Pijnappel, Pim W.W.M., Burlina, Alessandro P., In 't Groen, Stijn L.M., Gueraldi, Daniela, Cazzorla, Chiara, Maines, Evelina, Polo, Giulia, Salviati, Leonardo, Di Salvo, Giovanni, Burlina, Alberto B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597184/
https://www.ncbi.nlm.nih.gov/pubmed/36310651
http://dx.doi.org/10.1016/j.ymgmr.2022.100929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597184/
https://www.ncbi.nlm.nih.gov/pubmed/36310651
http://dx.doi.org/10.1016/j.ymgmr.2022.100929

Ejemplares similares